Deciphex: $32.3 Million (Series C) Raised For Addressing The Global Pathology Crisis
By Amit Chowdhry ● Jan 9, 2025
Deciphex, an AI-based digital pathology leader, announced it has closed its Series C funding at $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories, IRRUS Investments, HBAN Medtech Syndicate, and Nextsteps Capital, this funding will advance Deciphex's mission to democratize access to high-quality pathology through a technology-enabled global network of pathologists.